6.2 | | ftn-1 | 'daf-2(lf);cfim-1(lf)' vs 'wild type genotype' | genotype | 3'UTR sequencing of C.elegans strains |
5.9 | | ftn-1 | 'daf-2(lf)' vs 'wild type genotype' | genotype | 3'UTR sequencing of C.elegans strains |
5.8 | | ftn-1 | 'arsenic; 0.03 weight percent by volume' vs 'none; ' | compound | Expression data from L3 stage Caernorhabditis elegans after arsenic exposure |
-3.6 | | ftn-1 | 'mixed lawn (Escherichia coli OP50 and Bacillus subtilis PXN21)' vs 'Bacillus subtilis PXN21 lawn' | growth condition | RNAseq of young adult C. elegans animals fed on three different bacterial diets, E. coli OP50, B. subtilis PXN21 and a mixture of both |
3.2 | | ftn-1 | 'cfim-1(lf)' vs 'wild type genotype' | genotype | 3'UTR sequencing of C.elegans strains |
3.1 | | ftn-1 | 'cadmium' vs 'none' in 'wild type genotype' | compound, genotype | Transcription profiling by array of C. elegans with or without knockout of metallothionein (MT) grown in the presence or absence of cadmium to study the role of MT in the detoxification process |
-3.1 | | ftn-1 | 'experimental microbiome' vs 'E. coli OP50' in 'wild type genotype; none' | diet, genotype, stimulus | RNA-seq of C. elegans reared on experimental microbiome (EM) and EM cell-free media against OP50-fed controls |
2.7 | | ftn-1 | 'cadmium' vs 'none' in 'metallothionein knockout' | compound, genotype | Transcription profiling by array of C. elegans with or without knockout of metallothionein (MT) grown in the presence or absence of cadmium to study the role of MT in the detoxification process |
2.6 | | ftn-1 | 'daf-2(lf);daf-16(lf)' vs 'wild type genotype' | genotype | 3'UTR sequencing of C.elegans strains |
2.5 | | ftn-1 | 'arsenic; 0.003 weight percent by volume' vs 'none; ' | compound | Expression data from L3 stage Caernorhabditis elegans after arsenic exposure |
2.4 | | ftn-1 | 'starved' vs 'untreated' in 'wild type genotype' | genotype, growth condition | DAF-16/FoxO and EGL-27/GATA promote developmental growth in response to persistent somatic DNA damage [N2, xpa-1] |
-2.1 | | ftn-1 | 'clk-1(qm30); clk-1(WT)' vs 'clk-1(qm30)' in polysomal RNA | fraction, genotype | RNA-seq of total and polysomal RNA of clk-1(qm30) mutants in Caenorhabditis elegans |
2 | | ftn-1 | 'daf-2 mutant' vs 'wild type genotype' in 'UV irradiation' | genotype, growth condition | Transcription profiling by array of wild-type, daf-2 mutant, daf-16 mutant and daf-2;daf-16 double-mutant C. elegans irradiated by UV or starved to cause DNA damage against mock-irradiated controls |
-1.9 | | ftn-1 | 'clk-1(qm30); clk-1(WT)' vs 'clk-1(qm30)' in total RNA | fraction, genotype | RNA-seq of total and polysomal RNA of clk-1(qm30) mutants in Caenorhabditis elegans |
1.7 | | ftn-1 | 'GEI-8 mutant' vs 'wild type' | genotype | GEI-8, a homologue of vertebrate nuclear receptor corepressor NCoR/SMRT, regulates development and neuronal functions in C. elegans. |
1.6 | | ftn-1 | 'ethosuximide; dnj-14 mutant; OK237' vs 'vehicle; dnj-14 mutant; OK237' | compound, genotype, strain | Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression |
1.6 | | ftn-1 | 'ethosuximide; wild type genotype; CZ1200' vs 'vehicle; wild type genotype; CZ1200' | compound, genotype, strain | Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression |
1.4 | | ftn-1 | 'daf-2 mutant' vs 'wild type genotype' in 'mock control' | genotype, growth condition | Transcription profiling by array of wild-type, daf-2 mutant, daf-16 mutant and daf-2;daf-16 double-mutant C. elegans irradiated by UV or starved to cause DNA damage against mock-irradiated controls |
1.4 | | ftn-1 | 'ethosuximide; wild type genotype; N2' vs 'vehicle; wild type genotype; N2' | compound, genotype, strain | Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression |
-1.4 | | ftn-1 | 'daf-16 mutant' vs 'wild type genotype' in 'mock control' | genotype, growth condition | Transcription profiling by array of wild-type, daf-2 mutant, daf-16 mutant and daf-2;daf-16 double-mutant C. elegans irradiated by UV or starved to cause DNA damage against mock-irradiated controls |
-1.3 | | ftn-1 | 'metformin resistant OP50 E.coli' vs 'metformin sensitive OP50 E. coli' in '"metformin; 50 millimolar' | compound, growth condition | RNAseq of C. elegans cultured on metformin sensitive and resistant E. coli strains with and without 50mM metformin treatment. |
1.2 | | ftn-1 | 'ethosuximide; dnj-14 mutant; Tm3223' vs 'vehicle; dnj-14 mutant; Tm3223' | compound, genotype, strain | Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression |
-1.1 | | ftn-1 | 'UV irradiation' vs 'mock control' in 'wild type genotype' | genotype, growth condition | Transcription profiling by array of wild-type, daf-2 mutant, daf-16 mutant and daf-2;daf-16 double-mutant C. elegans irradiated by UV or starved to cause DNA damage against mock-irradiated controls |
1.1 | | ftn-1 | 'yersinia pestis (24h); pathogenic' vs 'E. coli OP50 (24h); nonpathogenic' | infect, phenotype | Transcription profiling by array of C. elegans gene expression in response to infection of pathogenic Y. pestis KIM5 compared to not pathogenic E. coli OP50 |
-1.1 | | ftn-1 | 'daf-2;daf-16 double mutant' vs 'wild type genotype' in 'mock control' | genotype, growth condition | Transcription profiling by array of wild-type, daf-2 mutant, daf-16 mutant and daf-2;daf-16 double-mutant C. elegans irradiated by UV or starved to cause DNA damage against mock-irradiated controls |
1.1 | | ftn-1 | 'metformin; 50 millimolar' vs 'none' in 'metformin sensitive OP50 E. coli' | compound, growth condition | RNAseq of C. elegans cultured on metformin sensitive and resistant E. coli strains with and without 50mM metformin treatment. |